HDAC8-IN-1-DataSheet-生命科學(xué)試劑-MedChemExpress

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemEHDAC8-IN-1Cat.No.:HY-111342CASNo.:1417997-93-3分?式:C??H??NO?分?量:345.39作?靶點:HDAC作?通路:CellCycle/DNADamage;Epigenetics儲存?式:Powder-20°C3years4°C2yearsInsolvent-80°C6months-20°C1month溶解性數(shù)據(jù)體外實驗DMSO:50mg/mL(144.76mM;ultrasonicandwarmingandheatto60°C)MassSolvent1mg5mg10mgConcentration制備儲備液1mM2.8953mL14.4764mL28.9528mL5mM0.5791mL2.8953mL5.7906mL10mM0.2895mL1.4476mL2.8953mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液；?旦配成溶液，請分裝保存，避免反復(fù)凍融造成的產(chǎn)品失效。儲備液的保存?式和期限：-80°C,6months;-20°C,1month。-80°C儲存時，請在6個?內(nèi)使?，-20°C儲存時，請在1個?內(nèi)使?。體內(nèi)實驗請根據(jù)您的實驗動物和給藥?式選擇適當(dāng)?shù)娜芙?案。以下溶解?案都請先按照InVitro?式配制澄的儲備液，再依次添加助溶劑：(為保證實驗結(jié)果的可靠性，澄的儲備液可以根據(jù)儲存條件，適當(dāng)保存；體內(nèi)實驗的?作液，建議您現(xiàn)?現(xiàn)配，當(dāng)天使?；以下溶劑前顯?的百分?指該溶劑在您配制終溶液中的體積占?；如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象，可以通過加熱和/或超聲的?式助溶)1.請依序添加每種溶劑：10%DMSO>>40%PEG300>>5%Tween-80>>45%salineSolubility:≥2.5mg/mL(7.24mM);Clearsolution1/2MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemE2.請依序添加每種溶劑：10%DMSO>>90%(20%SBE-β-CDinsaline)Solubility:≥2.5mg/mL(7.24mM);Clearsolution3.請依序添加每種溶劑：10%DMSO>>90%cornoilSolubility:≥2.5mg/mL(7.24mM);ClearsolutionBIOLOGICALACTIVITY?物活性HDAC8-IN-1?個HDAC8抑制劑，其IC50值為27.2nM。IC50&TargetHDAC827.2nM(IC50)體外研究HDAC8-IN-1isaHDAC8inhibitorwithanIC50of27.2nMincancercelllines.HDAC8-IN-1(compound22d)showsantiproliferativeeffectstowardseveralhumanlungcancercelllines(A549,H1299,andCL1-5);HDAC8-IN-1exhibitscytotoxicityagainsthumanlungCL1-5cellswithoutsignificantcytotoxicityfornormalIMR-90cells[1].戶使?本產(chǎn)品發(fā)表的科研?獻(xiàn)?CellDeathDis.2021May18;12(6):501.Seemorecustomervalidationsonwww.MedChemEREFERENCES[1].HuangWJ,etal.Synthesisandbiologicalevaluationofortho-arylN-hydroxycinnamidesaspotenthistonedeacetylase(HDAC)8isoform-selectiveinhibitors.ChemMedChem.2012Oct;7(10):1815-24.McePdfHeightCaution:Producthasnotbeenfullyvalidatedformedicalapplications.Forresearchuseonly.Tel:400